These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 23494221)

  • 1. Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma.
    Banzai C; Nishino K; Quan J; Yoshihara K; Sekine M; Yahata T; Tanaka K;
    Int J Clin Oncol; 2014 Feb; 19(1):127-32. PubMed ID: 23494221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DAPK1, MGMT and RARB promoter methylation as biomarkers for high-grade cervical lesions.
    Sun Y; Li S; Shen K; Ye S; Cao D; Yang J
    Int J Clin Exp Pathol; 2015; 8(11):14939-45. PubMed ID: 26823825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Promoter methylation of DAPK1, RAR-β and MGMT in exfoliated cervical cytology and its clinical application].
    Zhong ZJ; Yang JX; Cao DY; Sun Y; Sun LL; Cheng XM; Chen J; Lang JH; Shen K
    Zhonghua Fu Chan Ke Za Zhi; 2012 Mar; 47(3):196-200. PubMed ID: 22781071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients.
    Pierini S; Jordanov SH; Mitkova AV; Chalakov IJ; Melnicharov MB; Kunev KV; Mitev VI; Kaneva RP; Goranova TE
    Head Neck; 2014 Aug; 36(8):1103-8. PubMed ID: 23804521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter region hypermethylation and mRNA expression of MGMT and p16 genes in tissue and blood samples of human premalignant oral lesions and oral squamous cell carcinoma.
    Bhatia V; Goel MM; Makker A; Tewari S; Yadu A; Shilpi P; Kumar S; Agarwal SP; Goel SK
    Biomed Res Int; 2014; 2014():248419. PubMed ID: 24991542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of promoter hypermethylation in hTERT, DAPK and MGMT genes with cervical oncogenesis progression.
    Iliopoulos D; Oikonomou P; Messinis I; Tsezou A
    Oncol Rep; 2009 Jul; 22(1):199-204. PubMed ID: 19513524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kras gene mutation and RASSF1A, FHIT and MGMT gene promoter hypermethylation: indicators of tumor staging and metastasis in adenocarcinomatous sporadic colorectal cancer in Indian population.
    Sinha R; Hussain S; Mehrotra R; Kumar RS; Kumar K; Pande P; Doval DC; Basir SF; Bharadwaj M
    PLoS One; 2013; 8(4):e60142. PubMed ID: 23573237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel DNA methylation biomarkers for early diagnosis of oral tongue squamous cell carcinoma (OTSCC).
    Alafaria HAA; Jalal AS
    J Appl Genet; 2024 Sep; 65(3):541-548. PubMed ID: 38438717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based case-control study on DAPK1, RAR-β2 and MGMT methylation in liquid-based cytology.
    Sun LL; Cao DY; Yang JX; Li H; Zhou XR; Song ZQ; Cheng XM; Chen J; Shen K
    Arch Gynecol Obstet; 2012 May; 285(5):1433-9. PubMed ID: 22116316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between promoter methylation & tissue expression of MGMT gene in ovarian cancer.
    Shilpa V; Bhagat R; Premalata CS; Pallavi VR; Ramesh G; Krishnamoorthy L
    Indian J Med Res; 2014 Nov; 140(5):616-23. PubMed ID: 25579142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited Role of Promoter Methylation of
    Sun LL; Liu Y; Sun X; Pan L; Wu D; Wang YD
    Chin Med J (Engl); 2018 Apr; 131(8):939-944. PubMed ID: 29664054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The promoter hypermethylation status of GATA6, MGMT, and FHIT in glioblastoma.
    Cecener G; Tunca B; Egeli U; Bekar A; Tezcan G; Erturk E; Bayram N; Tolunay S
    Cell Mol Neurobiol; 2012 Mar; 32(2):237-44. PubMed ID: 21928112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between methylation of 5'-CpG islands and inactivation of FHIT gene in cervical cancer].
    Shi HR; Wu QH; Suo ZH; Nesland JM
    Ai Zheng; 2005 Jan; 24(1):7-11. PubMed ID: 15642192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of methylation markers for the prediction of nodal metastasis in oral and oropharyngeal squamous cell carcinoma.
    Melchers LJ; Clausen MJ; Mastik MF; Slagter-Menkema L; van der Wal JE; Wisman GB; Roodenburg JL; Schuuring E
    Epigenetics; 2015; 10(9):850-60. PubMed ID: 26213212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of MGMT promoter hypermethylation with squamous intraepithelial lesion and cervical carcinoma: A meta-analysis.
    Huang J; Luo JY; Tan HZ
    PLoS One; 2019; 14(10):e0222772. PubMed ID: 31574102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas.
    Psofaki V; Kalogera C; Tzambouras N; Stephanou D; Tsianos E; Seferiadis K; Kolios G
    World J Gastroenterol; 2010 Jul; 16(28):3553-60. PubMed ID: 20653064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between RARβ and FHIT promoter methylation and the carcinogenesis of patients with cervical carcinoma: A meta-analysis.
    Shu R; He J; Wu C; Gao J
    Tumour Biol; 2017 Jun; 39(6):1010428317709126. PubMed ID: 28639889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel epigenetic changes in CDKN2A are associated with progression of cervical intraepithelial neoplasia.
    Wijetunga NA; Belbin TJ; Burk RD; Whitney K; Abadi M; Greally JM; Einstein MH; Schlecht NF
    Gynecol Oncol; 2016 Sep; 142(3):566-73. PubMed ID: 27401842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade III.
    Terra AP; Murta EF; Maluf PJ; Caballero OL; Brait M; Adad SJ
    Tumori; 2007; 93(6):572-9. PubMed ID: 18338492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of aberrant promoter methylation of FHIT and RASSF1A genes on susceptibility to cervical cancer in a North Indian population.
    Neyaz MK; Kumar RS; Hussain S; Naqvi SH; Kohaar I; Thakur N; Kashyap V; Das BC; Husain SA; Bharadwaj M
    Biomarkers; 2008 Sep; 13(6):597-606. PubMed ID: 18608185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.